Yayın: Fusarium oxysporum infection of stasis ulcer: Eradication with measures aimed to improve stasis
| dc.contributor.author | Mansur, A. Tulin | |
| dc.contributor.author | Artunkal, Seza | |
| dc.contributor.buuauthor | Ener, Beyza | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Mikrobiyoloji Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-4803-8206 | |
| dc.contributor.researcherid | AAG-8523-2021 | |
| dc.contributor.scopusid | 15053025300 | |
| dc.date.accessioned | 2022-02-10T09:45:22Z | |
| dc.date.available | 2022-02-10T09:45:22Z | |
| dc.date.issued | 2011-07 | |
| dc.description.abstract | Fusarium species may cause localised skin infections in immunocompetent individuals. At least half of these infections are preceded by skin breakdown. The lesions are characterised by slow progression and good response to therapy. Here we present a 60-year-old non-diabetic man with stasis ulcers showing Fusarium oxysporum growth in culture of both pus swabs and skin biopsy specimens. The patient was confined to wheelchair because of recurrent sacral chordoma of 15 years duration, which was not under treatment for the last 3 years. Leg ulcers were resistant to antifungal therapy, and healed rapidly after improving of stasis with local and systemic measures. | |
| dc.identifier.citation | Mansur, A. T. vd. (2011). "Fusarium oxysporum infection of stasis ulcer: Eradication with measures aimed to improve stasis". Mycoses, 54(4), E205-E207. | |
| dc.identifier.doi | 10.1111/j.1439-0507.2009.01800.x | |
| dc.identifier.endpage | E207 | |
| dc.identifier.issn | 0933-7407 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pubmed | 19878456 | |
| dc.identifier.scopus | 2-s2.0-79959211882 | |
| dc.identifier.startpage | E205 | |
| dc.identifier.uri | https://doi.org/10.1111/j.1439-0507.2009.01800.x | |
| dc.identifier.uri | https://onlinelibrary.wiley.com/doi/full/10.1111/j.1439-0507.2009.01800.x | |
| dc.identifier.uri | http://hdl.handle.net/11452/24400 | |
| dc.identifier.volume | 54 | |
| dc.identifier.wos | 000292501600031 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.collaboration | Sanayi | |
| dc.relation.journal | Mycoses | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Dermatology | |
| dc.subject | Mycology | |
| dc.subject | Fusarium | |
| dc.subject | Fusarium oxysporum | |
| dc.subject.emtree | Acetic acid derivative | |
| dc.subject.emtree | Acetylsalicylic acid | |
| dc.subject.emtree | Amphotericin B | |
| dc.subject.emtree | C reactive protein | |
| dc.subject.emtree | Indapamide | |
| dc.subject.emtree | Itraconazole | |
| dc.subject.emtree | Lead subacetate | |
| dc.subject.emtree | Pentoxifylline | |
| dc.subject.emtree | Terbinafine | |
| dc.subject.emtree | Unclassified drug | |
| dc.subject.emtree | Voriconazole | |
| dc.subject.emtree | Zinc oxide | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Antifungal susceptibility | |
| dc.subject.emtree | Cancer radiotherapy | |
| dc.subject.emtree | Cancer surgery | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Chordoma | |
| dc.subject.emtree | Erythrocyte sedimentation rate | |
| dc.subject.emtree | Fungus culture | |
| dc.subject.emtree | Fungus growth | |
| dc.subject.emtree | Fusarium oxysporum | |
| dc.subject.emtree | Fusarium wilt | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Leg stasis ulcer | |
| dc.subject.emtree | Leg ulcer | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Physical examination | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Recurrent cancer | |
| dc.subject.emtree | Skin biopsy | |
| dc.subject.emtree | Wheelchair | |
| dc.subject.mesh | Antifungal agents | |
| dc.subject.mesh | Dermatologic agents | |
| dc.subject.mesh | Fusarium | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle aged | |
| dc.subject.mesh | Mycoses | |
| dc.subject.mesh | Organometallic compounds | |
| dc.subject.mesh | Pentoxifylline | |
| dc.subject.mesh | Platelet aggregation inhibitors | |
| dc.subject.mesh | Skin | |
| dc.subject.mesh | Suppuration | |
| dc.subject.mesh | Treatment outcome | |
| dc.subject.mesh | Varicose ulcer | |
| dc.subject.mesh | Zinc oxide | |
| dc.subject.scopus | Fusariosis; Fusarium Incarnatum; Chlamydospores | |
| dc.subject.wos | Dermatology | |
| dc.subject.wos | Mycology | |
| dc.title | Fusarium oxysporum infection of stasis ulcer: Eradication with measures aimed to improve stasis | |
| dc.type | Article | |
| dc.wos.quartile | Q2 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Mikrobiyoloji Ana Bilim Dalı | |
| local.indexed.at | Scopus | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
